DSpace at RU >

Browsing by Author Movig, K.L.L.

Full Text	Issue Date	Title	Author(s)
	2010	Effect of apomorphine on cognitive performance and sensorimotor gating in humans.	Schellekens, A.F.A.; Grootens, K.P.; Neef, C.; Movig, K.L.L.; Buitelaar, J.K., et al
	2010	Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.	Arbouw, M.E.; Movig, K.L.L.; Koopmann, M.; Poels, P.J.E.; Guchelaar, H.J., et al
	2009	Pharmacogenetic determinants for discontinuation of non-ergoline dopamine agonists in Parkinson's disease.	Arbouw, M.E.; Movig, K.L.L.; Egberts, T.C.G.; Poels, P.J.E.; Vugt, J.P.P. van, et al
	2009	Glycopyrroniumbromide for the treatment of sialorrhea in Parkinson's disease.	Arbouw, M.E.; Movig, K.L.L.; Koopmann, M.; Poels, P.J.E.; Guchelaar, H.J., et al
	2008	Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: clinical practice versus clinical trials.	Arbouw, M.E.; Movig, K.L.L.; Guchelaar, H.J.; Poels, P.J.P.; Vugt, J.P.A. van, et al
	2007	Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.	Wilting, I.; Baumgarten, R.; Movig, K.L.L.; Laarhoven, J. van; Apperloo, A.J., et al
	2005	Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice.	Wilting, I.; Movig, K.L.L.; Moolenaar, M.; Hekster, Y.A.; Brouwers, J.R.B.J., et al